Brain gene therapy tested for Parkinson's control
Disease control
Completed
This early-stage study tested the safety of a new gene therapy for Parkinson's disease. Fourteen participants with Parkinson's underwent a surgical procedure where a gene was delivered to a specific area of the brain. The goal was to see if this approach was safe and could help b…
Phase: PHASE1, PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC